Events

The Arab Health Conference 2015 in Dubai

The 40. Arab Health conference took place in Dubai from January 26th – 29th. It is considered as largest health care event in the Middle East and as second largest trade fair in the world. 4.000 exhibitors coming from 40 nations presented their innovations in the fields of e.g. diagnostics, laboratory equipment, imaging and information systems in the International Convention and Exhibition Center. More than 120.000 attendees and visitors were […]

People

“I have my little daughter close to me every day”

Jessica Rühs is medical technical assistant (MTA) at EUROIMMUN and likes that the company helps her to combine her professional career and her family. Please introduce yourself shortly and let us know how you came to EUROIMMUN. My name is Jessica and I did a vocational training in Schwerin to be a medical technical laboratory

Company

The EUROIMMUN family has a new member: France

The EUROIMMUN family is steadily growing and now has a new member: a new subsidiary in France. On the 1st April, we acquired 100 percent of the shares of BIO ADVANCE in Bussy-Saint-Martin near Paris and thus made it part of the EUROIMMUN group. EUROIMMUN products have been successfully distributed in France by BIO ADVANCE

Company

EUROIMMUN – a multinational company

At EUROIMMUN, worldwide over 1,800 colleagues of 35 different nationalities work hand in hand. EUROIMMUN fosters lasting and amicable relationships with subsidiaries and distributors in over 100 countries. We respect and value our employees, partners and friends – regardless of their nationality or religious orientation. We are extremely grateful to all colleagues who develop, produce

Events

Anti-PLA2R Antibodies – News from ASN Kidney Week 2014

EUROIMMUN US exhibited at the American Society of Nephrology (ASN) Kidney Week 2014, the premier international nephrology meeting, in Philadelphia November 11th-16th. More than 13,000 professionals participated and the EUROIMMUN attendees reported on valuable feedback regarding anti-PLA2R antibodies, the new biomarker of primary membranous nephropathy. “ASN went very well”, concluded Todd Walbrun, the National Accounts

Scroll to Top